Worth Venture Partners, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 214 filers reported holding IMMUNOMEDICS INC in Q3 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2018$3,271,000
+51.9%
396,000
-18.4%
2.70%
+44.3%
Q1 2018$2,154,000
+3.3%
485,300
+39.2%
1.87%
-18.7%
Q4 2017$2,085,000
+183.3%
348,600
+138.4%
2.31%
+261.4%
Q3 2017$736,000
+151.2%
146,200
+27.0%
0.64%
+152.2%
Q2 2017$293,000
+1623.5%
115,100
+746.3%
0.25%
+1586.7%
Q1 2017$17,00013,6000.02%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders